S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|New TECFIDERA® (Dimethyl Fumarate) Data Show Sustained Efficacy and Long-Term Safety in a Broad Range of Multiple Sclerosis Patients (2013/10/4)|
|“Dancing with the Stars” Finalist Jack Osbourne Offers Inside Look at His Life with Multiple Sclerosis through You Don’t Know Jack About MS™ Campaign (2013/12/4)|
|XenoPort Announces Preliminary Results of Phase 1 Studies Supporting Further Development of XP23829 ()|
|TRADE NEWS: Agilent Technologies Announces LTE-A Carrier Aggregation Support on Conformance and Design Verification Systems (2013/10/29)|
|CHMP Determines Dimethyl Fumarate in TECFIDERA® to be a New Active Substance in the European Union (2013/11/22)|
|European Commission Approves Genzyme’s Multiple Sclerosis Treatment Lemtrada™ (alemtuzumab) (2013/9/17)|
|Health Canada Approves Genzyme's AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Remitting Multiple Sclerosis (2013/11/20)|
|Biogen Idec to Present Extensive New Data from Its Robust Multiple Sclerosis Portfolio at ECTRIMS (2013/9/23)|
|New Clinical Insights and Data Presented at 29th ECTRIMS Congress Further Advance Teva’s Leadership in Multiple Sclerosis (2013/9/26)|
|New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity (2013/10/3)|
Click above to view more mutual fund data and stats for rrm - Ross River Minerals Inc..